Birmingham, West Midlands -- (SBWIRE) -- 01/08/2014 -- Value Penny Stocks issues special report on Kandi Technologies Group Inc (NASDAQ:KNDI), Hercules Offshore, Inc. (NASDAQ:HERO), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA).
Kandi Technologies Group Inc (NASDAQ:KNDI) ended its recent business day with the gain of 6.55% and closed at the price of $12.86 after opening at $12.15. The stock traded during its last trading session with the total volume of 3,653,940 shares, as compared to its average volume of 1.96 million shares. Kandi Technologies Group, Inc., through its subsidiaries, engages in the design, development, manufacture, and commercialization of various vehicles. It offers electrical vehicles, all-terrain vehicles, go-karts, and specialized automobiles.
For How Long KNDI will Fight for Profitability? Read This Trend Analysis report
Hercules Offshore, Inc. (NASDAQ:HERO) remained among the day decliners and traded with volume of 3,478,362 shares in the last session, as compared to average volume of 2.58 million shares. In comparison with 52 week range of $5.82 - $7.96, it faced lowest price of $6.30 during the last trading session whereas its day highest price was $6.54. The company’s total market capitalization is $1.01 billion, along with 159.75 million shares outstanding. Hercules Offshore, Inc., together with its subsidiaries, provides shallow-water drilling and marine services to the oil and natural gas exploration and production industry worldwide. The company operates through five segments: Domestic Offshore, International Offshore, Inland, Domestic Liftboats, and International Liftboats.
Has HERO Found The Bottom And Ready To Gain Momentum? Find Out Here
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) showed 3,368,541 shares in volume during the last trading session, while the average trading volume remained 4.30 million shares. The stock kicked off its trading session at $5.85 and closed at $5.83 after declining -0.34%. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
Why Should Investors Buy ARNA After the Recent Fall? Just Go Here and Find Out
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)